Shortly, pre-B cells on OP9/IL-7 were induced with doxycycline for 24 hours, thereafter transfected overnight in serum-free medium containing 10 ng/mL rIL-7 and 200 μL lipofection-mix with either the sensor or the mutated sensor construct, once medium changed and the cells analyzed with the dual luciferase reporter assay system (Promega) after 2 days. Data were normalized to the firefly luciferase expression. Antagomirs [24] with miR-221-complementary or with scrambled sequences were produced by Dharmacon. For the inhibition of the mature miR-221, the same protocol was used as described in [34]. Pre-B-cells were induced for miR-221 expression 24 hours

before transplantation in vitro with 1 μg doxycycline/mlL On the day of transplantation, the cells were incubated in serum-free ACCELL media supplemented with 1 μM antagomir R428 nmr 221 or scrambled for 1 hour at 37°C and then transplanted into doxycycline fed, sublethally irradiated Rag1−/− mice. Whole mouse genome MG 430 2.0 GeneChip from Affymetrix were used in triplicates. RNA isolation and chip hybridization was performed according to the manufacturer’s protocols as described in Biesen et al. [35] and was kindly realized by Andreas Grützkau and Heidi Schliemann (Deutsches

Rheuma-Forschungszentrum Berlin, Germany). Briefly, a maximum of 3 × 106 cells were lysed in 350 μL RLT buffer from Qiagen supplemented with β-ME (1:100 from a 10 M stock); 300 ng total RNA was reverse transcribed into cDNA and then in vitro transcribed to synthesize biotin-modified cRNA with IVT labeling. Fifteen micrograms quality-controlled cRNA were hybridized in triplicates Selumetinib in vitro to the microarrays. Chips were scanned with an Affymetrix GeneChip Scanner 3000 with the GCOS software. Data analysis was performed and described with Bioretis database using the default query parameters to filter the significant differentially regulated genes. Cluster analyses were performed with the tool Genes@Work,

with gene vector normalization and Pearson with mean as similarity measure [36]. The Data discussed in this publication has been deposited in NCBI’s GEO (GSE47643). We thank Dr. Carlo Croce (Human Cancer Genetics Program, Department of Molecular Virology, Immunology and Medical P-type ATPase Genetics, The Ohio State University, Columbus, OH, USA) and George A. Calin, then at the Jefferson Cancer Center of Jefferson University, Philadelphia, USA, for the generous help with the first microarray analysis reported in Supporting Information Fig. 1A. We thank Dr. Simon Fillatreau, Deutsches Rheumaforschungszentrum Berlin, Germany, for critical reading of our manuscript. We thank Jana Winckler and Lisa Zuechner for their professional help with experiments. We thank Heidi Schliemann for her professional help with the microarray experiments. Parts of this work was supported by a DFG-Kosellek Grant (ME2764/1-1) to F.M. M.K. was the recipient of a Max Planck Graduate Student stipend.